Synonyms
Microinvasive carcinoma, pT1mi, Invasive carcinoma less than or equal to 1 mm in greatest dimension
Definition
Microinvasive carcinoma (MIC) of the breast was not clearly characterized until 1997 when the Union for International Cancer Control (UICC) first included pT1mic in the TNM classification of breast carcinoma. It was defined as “invasive mammary carcinoma with no focus exceeding 1 mm in greatest dimension.”
This definition has been carried through many editions of the Cancer Staging Manual published by American Joint Committee on Cancer (AJCC) until the current edition (Amin et al. 2017) where it is reported as “an invasive carcinoma with no focus measured larger than 1 mm and classified as pT1mi. MIC is reported as nearly always encountered in a setting of ductal carcinoma in situ (DCIS) (Ductal Carcinoma In Situ) (Fig. 1, (a) H&E. (b) Immunostaining for smooth-muscle myosin heavy chain highlights myoepithelial cells around the DCIS, while it is absent in the...
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences and Further Reading
Amin, M. B., Edge, S. B., Greene, F. L., et al. (Eds.). (2017). AJCC cancer staging manual (8th ed.pp. 589–628). New York: Springer.
Bianchi, S., & Vezzosi V. (2008). Microinvasive Carcinoma of the Breast. Pathology and Oncology Research, 14, 105–111.
Cserni, G., Wells, C. A., Kaia, H., et al. (2016). Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markers. Virchows Archive, 468, 473–481.
Hilson, J. B., Schnitt, S. J., & Collins, L. C. (2009). Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: Biologic and diagnostic implications. The American Journal Surgical Pathology, 33, 227–232.
Hoda, S. A. (2014). Ductal carcinoma in situ. In S. A. Hoda, E. Brogi, F. C. Koerner, & P. P. Rosen (Eds.), Rosen’s breast pathology (4th ed., pp. 331–411). Philadelphia: Lippincott Williams & Wilkins.
Morita, M., Yamaguchi, R., Tanaka, M., et al. (2016). Two progressive pathways of microinvasive carcinoma: Low-grade luminal pathway and high grade HER2 pathway based on high tumor-infiltrating lymphocytes. Journal of Clinical Pathology, 69, 890–898.
Pinder, S. E., Ellis, I. O., Schnitt, S. J., et al. (2012). Microinvasive carcinoma. In S. R. Lakhani, I. O. Ellis, S. J. Schnitt, et al. (Eds.), WHO classification of tumours of the breast (pp. 96–97). Lyon: International Agency for Research on Cancer.
Schnitt, S. J., & Collins, L. C. (Eds.). (2013). Biopsy interpretation of the breast (2nd ed.pp. 267–281). Philadelphia: Lippincott Williams & Wilkins.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Bianchi, S., Vezzosi, V. (2020). Microinvasive Carcinoma of the Breast. In: Sapino, A., Kulka, J. (eds) Breast Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-62539-3_4765
Download citation
DOI: https://doi.org/10.1007/978-3-319-62539-3_4765
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62538-6
Online ISBN: 978-3-319-62539-3
eBook Packages: MedicineReference Module Medicine